In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
--------
Question: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Clean Water Compliance and 
Affordability Act''.

SEC. 2. INTEGRATED MUNICIPAL STORMWATER AND WASTEWATER APPROACH 
              FRAMEWORK.

    (a) In General.--In the first 5 fiscal years beginning after the 
date of enactment of this Act, the Administrator of the Environmental 
Protection Agency (referred to in this section as the 
``Administrator''), in coordination with appropriate State, local, and 
regional authorities, shall carry out a pilot program under which the 
Administrator shall work cooperatively with and facilitate the efforts 
of eligible municipalities to develop and implement integrated plans to 
meet wastewater and stormwater obligations of the eligible 
municipalities under the Federal Water Pollution Control Act (33 U.S.C. 
1251 et seq.) in a more cost-effective and flexible manner.
    (b) Framework.--The Administrator shall carry out the pilot program 
in a manner that is consistent with the Integrated Municipal Stormwater 
and Wastewater Approach Framework issued by the Environmental 
Protection Agency and dated May 2012.
    (c) Selection of Eligible Municipalities.--
            (1) In general.--The Administrator, in consultation with 
        States that have approved National Pollutant Discharge 
        Elimination System programs, shall select not less than 15 
        eligible municipalities to participate in the pilot program.
            (2) Eligible municipality.--An eligible municipality is a 
        county, city, town, township, or subdivision of a State or 
        local government that--
                    (A) qualifies as a National Pollutant Discharge 
                Elimination System permit holder or designee; or
                    (B) is a party to an administrative order, 
                administrative consent agreement, or judicial consent 
                decree to comply with the requirements of the Federal 
                Water Pollution Control Act (33 U.S.C. 1251 et seq.).
            (3) Selection factors.--
                    (A) In general.--In selecting the eligible 
                municipalities to participate in the pilot program, the 
                Administrator shall give priority to--
                            (i) eligible municipalities that are 
                        operating under an administrative order, 
                        administrative consent agreement, or judicial 
                        consent decree to comply with the requirements 
                        of the Federal Water Pollution Control Act (33 
                        U.S.C. 1251 et seq.);
                            (ii) eligible municipalities that are 
                        affected by affordability constraints in 
                        planning and implementing control measures to 
                        address wet weather discharges from wastewater 
                        and stormwater facilities of the eligible 
                        municipalities; and
                            (iii) eligible municipalities with a 
                        history of knowledgeable, detailed, and 
                        comprehensive efforts to develop integrated and 
                        adaptive clean water management practices.
                    (B) Use of adaptive management approaches.--In 
                selecting eligible municipalities to participate in the 
                pilot program, the Administrator may give priority to 
                an eligible municipality that is seeking to develop and 
                implement an integrated plan that includes adaptive 
                approaches to account for changed or future uncertain 
                circumstances, including--
                            (i) the use of new innovative technical or 
                        institutional approaches; and
                            (ii) the ability to adapt the integrated 
                        plan in response to new regulatory requirements 
                        and reductions in financial capability.
    (d) Approval of Integrated Plans.--
            (1) In general.--In approving the integrated plan of an 
        eligible municipality under the pilot program established under 
        subsection (a), the Administrator shall--
                    (A) account for the financial capability of the 
                eligible municipality to adequately address the 
                requirements of the Federal Water Pollution Control Act 
                (33 U.S.C. 1251 et seq.) that apply to the eligible 
                municipality;
                    (B) prioritize the obligations of the eligible 
                municipality under the Federal Water Pollution Control 
                Act (33 U.S.C. 1251 et seq.) according to the most 
                cost-effective and environmentally beneficial outcomes;
                    (C) account for the maintenance, operational, and 
                regulatory obligations of the eligible municipality; 
                and
                    (D) enable the eligible municipality to implement 
                innovative and flexible approaches to meet the 
                obligations of the eligible municipality under the 
                Federal Water Pollution Control Act (33 U.S.C. 1251 et 
                seq.).
            (2) Additional authorities.--In carrying out the pilot 
        program established under subsection (a), the Administrator 
        may, in full coordination and mutual agreement with an eligible 
        municipality selected to participate in the pilot program--
                    (A) extend the allowable national pollutant 
                discharge elimination system permit term under section 
                402 of the Federal Water Pollution Control Act (33 
                U.S.C. 1342) to a maximum of 25 years, and make 
                corresponding changes to any associated implementation 
                schedule;
                    (B) modify the implementation terms of a consent 
                decree entered into by the eligible municipality with 
                the Administrator pursuant to that Act; and
                    (C) provide additional regulatory flexibility under 
                the Federal Water Pollution Control Act (33 U.S.C. 1251 
                et seq.) in approving and implementing an integrated 
                plan that includes adaptive approaches in order to 
                encourage the innovation integral to such approaches.
    (e) Report to Congress.--Not later than 1 year after the date of 
enactment of this Act, and each year thereafter for 5 years, the 
Administrator shall submit to Congress a report on the results of the 
pilot program established under subsection (a), including a description 
of the specific outcomes expected to be achieved that will reduce the 
costs of complying with the requirements of the Federal Water Pollution 
Control Act (33 U.S.C. 1251 et seq.) for--
            (1) eligible municipalities participating in the pilot 
        program; and
            (2) eligible municipalities that are similarly situated but 
        not participating in the pilot program.

Answer: Clean Water Compliance and Affordability Act  This bill requires the Environmental Protection Agency (EPA) to carry out a pilot program to facilitate the efforts of eligible municipalities to develop and implement integrated plans to meet their wastewater and stormwater obligations under the Federal Water Pollution Control Act (commonly known as the Clean Water Act) in a cost-effective and flexible manner and consistent with the Integrated Municipal Stormwater and Wastewater Approach Framework issued by the EPA in May 2012. The pilot program must facilitate the efforts of at least 15 municipalities. A municipality is eligible to participate in the pilot program if it is: (1) a National Pollutant Discharge Elimination System (NPDES) permit holder or designee; or (2) a party to an administrative order, administrative consent agreement, or judicial consent decree to comply with the requirements of the Clean Water Act. The EPA must give priority to municipalities that: (1) are affected by affordability constraints in planning and implementing control measures addressing wet weather discharges from wastewater and stormwater facilities; and (2) have a history of knowledgeable, detailed, and comprehensive efforts to develop integrated and adaptive clean water management practices. The EPA may give priority to municipalities seeking to develop and implement an integrated plan that includes approaches that adapt to changed or future uncertain circumstances. With the mutual agreement of participating municipalities, the EPA may: (1) extend the allowable NPDES permit term by up to 25 years, (2) modify the implementation terms of a consent decree, and (3) provide additional regulatory flexibility in approving and implementing an integrated plan that includes adaptive approaches.


Question: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Regulatory Transparency, Patient 
Access, and Effective Drug Enforcement Act of 2014''.

SEC. 2. SCHEDULING OF SUBSTANCES INCLUDED IN NEW FDA-APPROVED DRUGS.

    Section 201 of the Controlled Substances Act (21 U.S.C. 811) is 
amended by inserting after subsection (h) the following:
    ``(i) Within 45 days of receiving a recommendation from the 
Secretary to add a drug or substance that has never been marketed in 
the United States to a schedule under this title, the Attorney General 
shall, without regard to the findings required by subsection (a) of 
this section or section 202(b), issue an interim final rule, under the 
exception for good cause described in subparagraph (B) of section 
553(b) of title 5, United States Code, placing the drug or substance 
into the schedule recommended by the Secretary. The interim final rule 
shall be made immediately effective under section 553(d)(3) of title 5, 
United States Code.''.

SEC. 3. ENHANCING NEW DRUG DEVELOPMENT.

    Section 302 of the Controlled Substances Act (21 U.S.C. 822) is 
amended by inserting after subsection (g) the following:
    ``(h)(1) A person who submits an application for registration to 
manufacture or distribute a controlled substance in accordance with 
this section may indicate on the registration application that the 
substance will be used only in connection with clinical trials of a 
drug in accordance with section 505(i) of the Federal Food, Drug, and 
Cosmetic Act.
    ``(2) When an application for registration to manufacture or 
distribute a controlled substance includes an indication that the 
controlled substance will be used only in connection with clinical 
trials of a drug in accordance with section 505(i) of the Federal Food, 
Drug, and Cosmetic Act, the Attorney General shall--
            ``(A) make a final decision on the application for 
        registration within 180 days; or
            ``(B) provide notice to the applicant in writing of--
                    ``(i) the outstanding issues that must be resolved 
                in order to reach a final decision on the application; 
                and
                    ``(ii) the estimated date on which a final decision 
                on the application will be made.''.

SEC. 4. REGISTRATION PROCESS UNDER CONTROLLED SUBSTANCES ACT.

    (a) Definitions.--
            (1) Factors as may be relevant to and consistent with the 
        public health and safety.--Section 303 of the Controlled 
        Substances Act (21 U.S.C. 823) is amended by adding at the end 
        the following:
    ``(i) In this section, the phrase `factors as may be relevant to 
and consistent with the public health and safety' means factors that 
are relevant to and consistent with the findings contained in section 
101.''.
            (2) Imminent danger to the public health or safety.--
        Section 304(d) of the Controlled Substances Act (21 U.S.C. 
        824(d)) is amended--
                    (A) by striking ``(d) The Attorney General'' and 
                inserting ``(d)(1) The Attorney General''; and
                    (B) by adding at the end the following:
    ``(2) In this subsection, the phrase `imminent danger to the public 
health or safety' means that, in the absence of an immediate suspension 
order, controlled substances will continue to be distributed or 
dispensed by a registrant who knows or should know through fulfilling 
the obligations of the registrant under this Act, or has reason to 
believe that--
            ``(A) the dispensing is outside the usual course of 
        professional practice;
            ``(B) the distribution or dispensing poses a present or 
        foreseeable risk of adverse health consequences or death due to 
        the abuse or misuse of the controlled substances; or
            ``(C) the controlled substances will continue to be 
        diverted outside of legitimate distribution channels.''.
    (b) Opportunity To Submit Corrective Action Plan Prior to 
Revocation or Suspension.--Subsection (c) of section 304 of the 
Controlled Substances Act (21 U.S.C. 824) is amended--
            (1) by striking the last two sentences;
            (2) by striking ``(c) Before'' and inserting ``(c)(1) 
        Before''; and
            (3) by adding at the end the following:
    ``(2) An order to show cause under paragraph (1) shall--
            ``(A) contain a statement of the basis for the denial, 
        revocation, or suspension, including specific citations to any 
        laws or regulations alleged to be violated by the applicant or 
        registrant;
            ``(B) direct the applicant or registrant to appear before 
        the Attorney General at a time and place stated in the order, 
        but not less than 30 days after the date of receipt of the 
        order; and
            ``(C) notify the applicant or registrant of the opportunity 
        to submit a corrective action plan on or before the date of 
        appearance.
    ``(3) Upon review of any corrective action plan submitted by an 
applicant or registrant pursuant to paragraph (2), the Attorney General 
shall determine whether denial, revocation or suspension proceedings 
should be discontinued, or deferred for the purposes of modification, 
amendment, or clarification to such plan.
    ``(4) Proceedings to deny, revoke, or suspend shall be conducted 
pursuant to this section in accordance with subchapter II of chapter 5 
of title 5, United States Code. Such proceedings shall be independent 
of, and not in lieu of, criminal prosecutions or other proceedings 
under this title or any other law of the United States.
    ``(5) The requirements of this subsection shall not apply to the 
issuance of an immediate suspension order under subsection (d).''.

SEC. 5. REPORT TO CONGRESS ON EFFECTS OF LAW ENFORCEMENT ACTIVITIES ON 
              PATIENT ACCESS TO MEDICATIONS.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Secretary of Health and Human Services, acting through 
the Commissioner of Food and Drugs and the Director of the Centers for 
Disease Control and Prevention, and in consultation with the 
Administrator of the Drug Enforcement Administration and the Director 
of National Drug Control Policy, shall submit a report to the 
Committees on the Judiciary of the House of Representatives, the 
Committee on Energy and Commerce of the House of Representatives, the 
Committee on the Judiciary of the Senate, and the Committee on Health, 
Education, Labor and Pensions of the Senate identifying--
            (1) obstacles to legitimate patient access to controlled 
        substances;
            (2) issues with diversion of controlled substances; and
            (3) how collaboration between Federal, State, local, and 
        tribal law enforcement agencies and the pharmaceutical industry 
        can benefit patients and prevent diversion and abuse of 
        controlled substances.
    (b) Consultation.--The report under subsection (a) shall 
incorporate feedback and recommendations from the following:
            (1) Patient groups.
            (2) Pharmacies.
            (3) Drug manufacturers.
            (4) Common or contract carriers and warehousemen.
            (5) Hospitals, physicians, and other health care providers.
            (6) State attorneys general.
            (7) Federal, State, local, and tribal law enforcement 
        agencies.
            (8) Health insurance providers and entities that provide 
        pharmacy benefit management services on behalf of a health 
        insurance provider.
            (9) Wholesale drug distributors.

Answer: Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to direct the Attorney General, within 45 days of receiving a recommendation from the Secretary of Health and Human Services (HHS) to add a drug or substance that has never been marketed in the United States to a schedule of controlled substances, to issue an interim final rule under the exception for good cause, placing it into the schedule recommended, effective immediately. Allows a person who submits an application for registration to manufacture or distribute a controlled substance to indicate on the registration application that the substance will be used only in connection with clinical trials of a drug. Requires the Attorney General to: (1) make a final decision on such application within 180 days, or (2) provide written notice to the applicant of the outstanding issues that must be resolved to reach a final decision and the estimated date on which such decision will be made. Defines: (1) "factors as may be relevant to and consistent with the public health and safety," and (2) "imminent danger to the public health or safety." Requires an order to show cause as to why a registration should not be denied, revoked, or suspended to notify the registrant of the opportunity to submit a corrective action plan on or before the date of appearance before the Attorney General. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modification or clarification of such plan. Makes these requirements inapplicable to the issuance of an immediate suspension order. Directs the Secretary, acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to identify: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.


Question: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Small Business Regulatory Relief Act 
of 2017''.

SEC. 2. DEFINITIONS.

    In this Act--
            (1) the term ``Ombudsman'' has the meaning given that term 
        in section 30(a) of the Small Business Act 15 U.S.C. 657(a)); 
        and
            (2) the term ``small business concern'' has the meaning 
        given that term under section 3 of the Small Business Act (15 
        U.S.C. 632).

SEC. 3. SBA REGULATORY ENFORCEMENT OMBUDSMAN.

    (a) In General.--Section 30(b) of the Small Business Act (15 U.S.C. 
657(b)(2)) is amended--
            (1) in paragraph (2)--
                    (A) in subparagraph (A)--
                            (i) by striking ``with each agency with 
                        regulatory authority'' and inserting the 
                        following: ``with--
                            ``(i) each Federal agency with regulatory 
                        authority'';
                            (ii) by inserting ``and'' after the 
                        semicolon; and
                            (iii) by adding at the end the following:
                            ``(ii) each Federal agency with regulatory 
                        authority over small business concerns or that 
                        makes grants or enters into contracts or 
                        cooperative agreements with small business 
                        concerns to develop best practices to assist 
                        the Federal agency in--
                                    ``(I) establishing a program to 
                                assist small entities, as defined in 
                                section 601 of title 5, United States 
                                Code, in meeting regulatory 
                                requirements imposed by that Federal 
                                agency, including by responding to 
                                inquiries under section 213 of the 
                                Small Business Regulatory Enforcement 
                                Fairness Act of 1996 (5 U.S.C. 601 
                                note);
                                    ``(II) educating small entities 
                                about the regulations of that Federal 
                                agency that are applicable to small 
                                entities;
                                    ``(III) training small entities to 
                                comply with the regulations of that 
                                Federal agency;
                                    ``(IV) assisting small entities in 
                                completing forms required by the 
                                regulations of that Federal agency;
                                    ``(V) addressing any specific 
                                question or concern of small entities;
                                    ``(VI) evaluating compliance guides 
                                described under section 212 of the 
                                Small Business Regulatory Enforcement 
                                Fairness Act of 1996 (5 U.S.C. 601 
                                note);
                                    ``(VII) ensuring that the 
                                compliance guides described in 
                                subclause (VI) are available to small 
                                business development centers and to 
                                other resource partners of the 
                                Administration;
                                    ``(VIII) developing webinars 
                                relating to compliance assistance for--
                                            ``(aa) recently finalized 
                                        rules of the Federal agency; 
                                        and
                                            ``(bb) rules relating to 
                                        which the Federal agency or 
                                        Ombudsman receives a 
                                        significant number of 
                                        compliance inquiries from small 
                                        business concerns; and
                                    ``(IX) conducting customer service 
                                surveys on an ongoing basis of small 
                                business concerns that interact with 
                                the Federal agency to assess the 
                                timeliness and quality of the 
                                activities of the Federal agency, which 
                                shall be conducted in a manner that 
                                allows the results of the surveys to be 
                                incorporated into the rating of the 
                                responsiveness of the Federal agency 
                                under subparagraph (C);'';
                    (B) in subparagraph (D), by striking ``and'' at the 
                end;
                    (C) in subparagraph (E), by striking the period and 
                inserting a semicolon; and
                    (D) by adding at the end the following:
                    ``(F) in collaboration with the employee of a 
                Federal agency designated by the head of the Federal 
                agency as the primary point of contact with the 
                Ombudsman, establish a procedure relating to how the 
                Federal agency will provide information--
                            ``(i) to small business concerns regarding 
                        the Ombudsman; and
                            ``(ii) to the Ombudsman regarding the 
                        nature, scope, and resolution of requests to 
                        the Federal agency from small business concerns 
                        about proposed, final, or existing rules;
                    ``(G) work with each Federal agency with regulatory 
                authority over small business concerns and with 
                programs of the Administration (including the Service 
                Corps of Retired Executives authorized under section 
                8(b)(1)(B), women's business centers operating under 
                section 29, and small business development centers) to 
                conduct a robust outreach initiative, including through 
                the use of the Internet, to increase the visibility of 
                the Ombudsman and promote awareness of the services 
                available from the Ombudsman; and
                    ``(H) make information regarding the education, 
                training, and compliance assistance services of the 
                Ombudsman readily available on the website of the 
                Ombudsman.''; and
            (2) by adding at the end the following:
            ``(3)(A) The head of each Federal agency with regulatory 
        authority over small business concerns or that makes grants or 
        enters into contracts or cooperative agreements with small 
        business concerns shall designate an employee of the Federal 
        agency as the primary point of contact with the Ombudsman.
            ``(B) The employee designated under subparagraph (A) shall 
        have the authority to make changes necessary to address 
        compliance issues raised by small business concerns.''.
    (b) Resources.--The Ombudsman shall appoint additional individuals 
to positions in which they will provide education, training, and 
compliance assistance to small business concerns.

SEC. 4. AUTHORIZATION OF APPROPRIATIONS.

    Section 30 of the Small Business Act (15 U.S.C. 657) is amended by 
adding at the end the following:
    ``(e) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section such sums as are necessary.''.

Answer:
Small Business Regulatory Relief Act of 2017 This bill amends the Small Business Act to revise the duties of the Office of the National Ombudsman (ONO) to include working with federal agencies that have regulatory authority over small businesses or that provide support to small businesses to develop best practices for helping small businesses comply with agency rules through training, webinars, and compliance guides. The ONO must collaborate with each federal agency to establish a procedure relating to how the agency will provide information to: (1) small businesses regarding the ONO; and (2) the ONO regarding the nature, scope, and resolution of requests to the agency from small businesses about proposed, final, or existing rules. The ONO must:   conduct a robust outreach initiative to increase its visibility and promote awareness of its available services; and appoint additional individuals to provide education, training, and compliance assistance to small businesses.